Related Experiment Video
Updated: Oct 8, 2025
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
Published on: March 18, 2015
Tissue-engineered vascular grafts and regeneration mechanisms
Yongzhen Wei1, Fei Wang2, Zhikun Guo3
1Zhengzhou Cardiovascular Hospital and 7th People's Hospital of Zhengzhou, Zhengzhou, Henan Province, China; State key Laboratory of Medicinal Chemical Biology & Key Laboratory of Bioactive Materials (Ministry of Education), College of Life Sciences, Nankai University, Tianjin, China.
Tissue engineered vascular grafts (TEVGs) offer a promising alternative to autografts for treating cardiovascular diseases (CVDs). This review explores TEVG preparation, patency, regeneration, and host cell mechanisms for CVD treatment.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cardiovascular Surgery
Background:
- Cardiovascular diseases (CVDs) present a significant global health burden with high mortality rates.
- Vascular bypass surgery remains a critical treatment, but autograft limitations necessitate alternatives.
- Tissue engineered vascular grafts (TEVGs) are being developed to address the shortage of suitable autografts.
Purpose of the Study:
- To review current strategies for preparing TEVGs.
- To discuss factors influencing graft patency and tissue regeneration.
- To explore host cell-mediated mechanisms in vascular regeneration.
Main Methods:
- Literature review of TEVG preparation techniques.
- Analysis of factors impacting vascular graft performance.
- Discussion of host cell interactions in vascular repair.
Main Results:
- Various TEVG fabrication methods exist, each with unique advantages and challenges.
- Graft patency and successful tissue regeneration are influenced by material properties and biological integration.
- Host cells play a crucial role in the remodeling and long-term function of TEVGs.
Conclusions:
- TEVGs represent a viable alternative to autografts for cardiovascular reconstruction.
- Optimizing TEVG design and understanding host cell interactions are key to improving clinical outcomes.
- Further research into vascular regeneration mechanisms will advance TEVG technology for CVD treatment.
